✦ LIBER ✦

A novel HCV NS3 protease mutation selected by combination treatment of the protease inhibitor boceprevir and NS5B polymerase inhibitors

✍ Scribed by Robert Chase; Angela Skelton; Ellen Xia; Stephanie Curry; Shaotang Liu; Patricia McMonagle; H.-C. Huang; Xiao Tong

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Boceprevir: A Novel NS3/4 Protease Inhib

✍ Olga M. Klibanov; Stephen B. Vickery; Jacqueline L. Olin; Lisa S. Smith; Shannon 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 128 KB

Treatment of HCV infection with the nove

✍ De Luca, Andrea; Bianco, Claudia; Rossetti, Barbara 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 360 KB

867 IN VITRO COMBINATORY EFFECT OF HCV N

✍ T. Pilot-Matias; G. Koev; P. Krishnan; J. Beyer; T. Reisch; R. Mondal; L. Lu; T. 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 64 KB

[791] HCV ANTIVIRAL ACTIVITY AND RESISTA

✍ D.B. Olsen; S.S. Carroll; L. Handt; S. Ludmerer; D. Graham; C. Fandozzi; J. DeLu 📂 Article 📅 2007 🏛 Elsevier Science 🌐 English ⚖ 151 KB

Comparison of HCV NS3 protease and NS5B

✍ Matthew S. Paulson; Huiling Yang; I-hung Shih; Joy Y. Feng; Eric M. Mabery; Marg 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 544 KB

954 BI 201335, A POTENT HCV NS3 PROTEASE

✍ G. Kukolj; Y. Benhamou; M.P. Manns; M. Bourlière; S. Pol; M. Schuchmann; M. Cart 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 52 KB